Skip to content
God Of Sound – Lifestyle
Author:
Kelun-Biotech
Kelun-Biotech Presents Pivotal Phase II Data for Lunbotinib Fumarate (A400/EP0031) in RET Fusion-Positive NSCLC at 2026 ASCO
May 29, 2026
←
Previous Page
1
2